Investor Presentaiton

We are driving improved operational efficiency to accelerate speed to market Early Phase Phase III Development (I/II) Submission Activities Active future timeline Reduction from previous timeline Optimized study design World-class trial operations capabilities, ~40 countries footprint, robust site & patient engagement strategies Near-time data review and submissions Further enabled through Digital Innovation & Al Ill Bristol Myers Squibb™ Not for Product Promotional Use 132

View entire presentation